Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 1.000 | None | 0.977 | 8 | 0 | 1982 | 2020 | ||||||||
|
proteolipid protein 1 | 0.543 | 0.769 | 0.93 |
|
disease | 1.000 | definitive | 0.979 | 8 | 0 | 1962 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 1.000 | definitive | 0.982 | 8 | 0 | 2001 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 1.000 | None | 0.953 | 8 | 0 | 1987 | 2020 | ||||||||
|
RUNX family transcription factor 2 | 0.437 | 0.846 | 0.95 |
|
disease | 1.000 | None | 0.976 | 8 | 0 | 1997 | 2019 | ||||||||
|
solute carrier family 7 member 9 | 0.666 | 0.692 | 9.1E-10 |
|
disease | 1.000 | definitive | 1.000 | 7 | 0 | 1999 | 2018 | ||||||||
|
coagulation factor IX | 0.465 | 0.885 | 1.00 |
|
disease | 1.000 | definitive | 0.979 | 7 | 0 | 1976 | 2020 | ||||||||
|
coagulation factor XI | 0.590 | 0.692 | 3.6E-26 |
|
disease | 1.000 | strong | 1.000 | 7 | 0 | 1981 | 2019 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 1.000 | definitive | 0.974 | 7 | 0 | 1994 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 1.000 | strong | 0.989 | 7 | 0 | 1992 | 2020 | ||||||||
|
nibrin | 0.467 | 0.808 | 2.2E-16 |
|
disease | 1.000 | definitive | 0.981 | 7 | 0 | 1985 | 2019 | ||||||||
|
ribosomal protein S6 kinase A3 | 0.491 | 0.846 | 1.00 |
|
disease | 1.000 | definitive | 0.983 | 7 | 0 | 1996 | 2020 | ||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 1.000 | None | 1.000 | 7 | 0 | 1993 | 2019 | ||||||||
|
7-dehydrocholesterol reductase | 0.500 | 0.846 | 3.9E-13 |
|
disease | 1.000 | definitive | 0.987 | 6 | 0 | 1987 | 2018 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
disease | 1.000 | None | 1.000 | 6 | 0 | 1975 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 1.000 | None | 0.960 | 6 | 0 | 1990 | 2019 | ||||||||
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma | 0.493 | 0.769 | 8.5E-02 |
|
disease | 1.000 | None | 0.987 | 6 | 0 | 1976 | 2019 | ||||||||
|
elongator complex protein 1 | 0.579 | 0.769 | 2.1E-21 |
|
disease | 1.000 | None | 1.000 | 6 | 0 | 1993 | 2019 | ||||||||
|
CHM Rab escort protein | 0.592 | 0.654 | 1.00 |
|
disease | 1.000 | None | 0.965 | 5 | 0 | 1987 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 1.000 | strong | 1.000 | 5 | 0 | 1996 | 2020 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 1.000 | definitive | 1.000 | 5 | 0 | 1997 | 2019 | ||||||||
|
lysosomal associated membrane protein 2 | 0.552 | 0.731 | 0.27 |
|
disease | 1.000 | definitive | 1.000 | 5 | 0 | 1995 | 2020 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 1.000 | None | 0.978 | 5 | 0 | 1995 | 2020 | ||||||||
|
neurofibromin 2 | 0.468 | 0.885 | 1.00 |
|
disease | 1.000 | definitive | 0.987 | 5 | 0 | 1991 | 2020 | ||||||||
|
UDP glucuronosyltransferase family 1 member A1 | 0.464 | 0.769 | 3.3E-06 |
|
disease | 1.000 | None | 0.984 | 5 | 0 | 1992 | 2019 |